Choo R, Grimard L, Esche B, Crook J, Genest P, Odell P
Department of Radiation Oncology, Ottawa Regional Cancer Centre, Ontario, Canada.
J Otolaryngol. 1993 Feb;22(1):54-7.
Brachytherapy with iridium 192 was used in 20 patients with recurrent or persistent neck metastases from a primary head and neck carcinoma. Nine patients had intra-operative brachytherapy in combination with a neck dissection. Three patients had an implant as a boost following external beam radiotherapy. Eight patients were treated by brachytherapy alone for unresectable neck recurrence ranging from 5 to 10 cm in diameter. Nineteen patients were evaluable for neck control: 15 patients had complete clearance of tumor and 13 patients were controlled at time of death or last follow-up. There were few complications from treatment. Five patients are alive at 5, 14, 16, 22, and 27 months post-implant with two patients having developed a second primary. Seven patients died from distant metastases, four from regional disease and four from intercurrent illness. Indications are summarized for this frequently forgotten but useful last option for patients with persistent or recurrent neck metastases.
对20例原发性头颈癌颈部复发或持续性转移患者采用铱192近距离放射治疗。9例患者术中进行近距离放射治疗并联合颈部清扫术。3例患者在体外放射治疗后植入放射源作为增强治疗。8例直径5至10厘米的不可切除颈部复发患者仅接受近距离放射治疗。19例患者可评估颈部控制情况:15例患者肿瘤完全清除,13例患者在死亡或最后一次随访时病情得到控制。治疗并发症很少。5例患者在植入后5、14、16、22和27个月存活,其中2例发生了第二原发性肿瘤。7例患者死于远处转移,4例死于局部疾病,4例死于并发疾病。总结了对于颈部持续性或复发性转移患者这一常被遗忘但有用的最终选择的适应证。